The effect of moclobemide, reversible inhibitor of monoamine oxidase-A, on the alcoholized rat brain

被引:0
|
作者
Karaöz, E [1 ]
Kanter, M
Bapçi, Z
机构
[1] Suleyman Demirel Univ, Dept Histol & Embryol, Fac Med, Isparta, Turkey
[2] Gulhane Mil Med Acad, Dept Pharmacol, Ankara, Turkey
[3] Yuzuncu Yil Univ, Fac Vet Med, Dept Histol & Embryol, TR-65080 Kampus, Van, Turkey
关键词
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
This experiment was carried out to demonstrate the effect of moclobemide on the brains of rats fed on a diet containing alcohol. Thirty male rats, 200250 g were used. Rats were fed with a diet (milk) containing ethyl alcohol (10%) in the alcohol-only treated group and were injected subcutaneously with moclobemide (30 mg/kg) in the alcohol+moclobemide treated group daily for 21 days. It is found that the serum ethanol level in the alcohol+moclobemide treated group was significantly higher than in alcohol-only treated group at the end of the experiment. Electron microscopic examination revealed more prominent neurotoxicity in the alcohol+moclobemide treated group than in alcohol-only treated group. We concluded that moclobemide decreases the elimination of ethanol. However, more studies are needed to demonstrate its mechanism.
引用
下载
收藏
页码:217 / 225
页数:9
相关论文
共 50 条
  • [31] BROFAROMINE IN PANIC DISORDER - A PILOT-STUDY WITH A NEW REVERSIBLE INHIBITOR OF MONOAMINE OXIDASE-A
    GARCIABORREGUERO, D
    LAUER, CJ
    OZDAGLAR, A
    WIEDEMANN, K
    HOLSBOER, F
    KRIEG, JC
    PHARMACOPSYCHIATRY, 1992, 25 (06) : 261 - 264
  • [32] Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor .2. Pharmacological profile
    Caille, D
    Bergis, OE
    Fankhauser, C
    Gardes, A
    Adam, R
    Charieras, T
    Grosset, A
    Rovei, V
    Jarreau, FX
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 277 (01): : 265 - 277
  • [33] CLINICAL-PHARMACOLOGY OF REVERSIBLE MONOAMINE OXIDASE-A INHIBITORS
    BIECK, PR
    ANTONIN, KH
    SCHMIDT, E
    CLINICAL NEUROPHARMACOLOGY, 1993, 16 : S34 - S41
  • [34] EFFECT OF NEW MONOAMINE OXIDASE-A INHIBITORS ON NOCICEPTIVE THRESHOLDS IN THE RAT
    BIANCHI, M
    PANERAI, AE
    PHARMACOLOGICAL RESEARCH, 1992, 25 : 224 - 225
  • [35] THE EFFECT OF MONOAMINE OXIDASE-A AND OXIDASE-B INHIBITORS ON RAT SERUM PROLACTIN
    KEANE, PE
    MENAGER, J
    BENEDETTI, MS
    NEUROPHARMACOLOGY, 1981, 20 (12A) : 1157 - 1162
  • [36] HISTOCHEMICAL-LOCALIZATION OF MONOAMINE OXIDASE-A AND OXIDASE-B IN RAT-BRAIN
    WILLOUGHBY, J
    GLOVER, V
    SANDLER, M
    JOURNAL OF NEURAL TRANSMISSION, 1988, 74 (01) : 29 - 42
  • [38] Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor .1. Biochemical profile
    Curet, O
    Damoiseau, G
    Aubin, N
    Sontag, N
    Rovei, V
    Jarreau, FX
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 277 (01): : 253 - 264
  • [39] REVERSIBLE MONOAMINE OXIDASE-A INHIBITORS IN RESISTANT MAJOR DEPRESSION
    NOLEN, WA
    HOENCAMP, E
    BOUVY, PF
    HAFFMANS, PMJ
    CLINICAL NEUROPHARMACOLOGY, 1993, 16 : S69 - S76
  • [40] THE THERAPEUTIC POTENTIAL OF MOCLOBEMIDE, A REVERSIBLE SELECTIVE MONOAMINE-OXIDASE-A INHIBITOR IN PARKINSONS-DISEASE
    SIERADZAN, K
    CHANNON, S
    RAMPONI, C
    STERN, GM
    LEES, AJ
    YOUDIM, MBH
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (04) : S51 - S59